• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Pharmaceuticals in Belgium - Product Image

Pharmaceuticals in Belgium

  • ID: 2064138
  • April 2014
  • Region: Belgium
  • 34 pages
  • MarketLine

Introduction

Pharmaceuticals in Belgium industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Belgium pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2013 annual average exchange rates.

- The Belgian pharmaceuticals market had total revenues of $5.7bn in 2013, representing a compound annual rate of change (CARC) of -0.2% between 2009 and 2013.

- The performance of the market is forecast READ MORE >

Note: Product cover images may vary from those shown

Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
AstraZeneca PLC
GlaxoSmithKline Plc
Pfizer Inc.
Macroeconomic Indicators
Country Data
Appendix
Methodology
Industry associations
Related MarketLine research

LIST OF TABLES
Table 1: Belgium pharmaceuticals market value: $ billion, 2009–13
Table 2: Belgium pharmaceuticals market geography segmentation: $ billion, 2013
Table 3: Belgium pharmaceuticals market share: % share, by value, 2013
Table 4: Belgium pharmaceuticals market value forecast: $ billion, 2013–18
Table 5: AstraZeneca PLC: key facts
Table 6: AstraZeneca PLC: key financials ($)
Table 7: AstraZeneca PLC: key financial ratios
Table 8: GlaxoSmithKline Plc: key facts
Table 9: GlaxoSmithKline Plc: key financials ($)
Table 10: GlaxoSmithKline Plc: key financials (£)
Table 11: GlaxoSmithKline Plc: key financial ratios
Table 12: Pfizer Inc.: key facts
Table 13: Pfizer Inc.: key financials ($)
Table 14: Pfizer Inc.: key financial ratios
Table 15: Belgium size of population (million), 2009–13
Table 16: Belgium gdp (constant 2000 prices, $ billion), 2009–13
Table 17: Belgium gdp (current prices, $ billion), 2009–13
Table 18: Belgium inflation, 2009–13
Table 19: Belgium consumer price index (absolute), 2009–13
Table 20: Belgium exchange rate, 2009–13

LIST OF FIGURES
Figure 1: Belgium pharmaceuticals market value: $ billion, 2009–13
Figure 2: Belgium pharmaceuticals market geography segmentation: % share, by value, 2013
Figure 3: Belgium pharmaceuticals market share: % share, by value, 2013
Figure 4: Belgium pharmaceuticals market value forecast: $ billion, 2013–18
Figure 5: Forces driving competition in the pharmaceuticals market in Belgium, 2013
Figure 6: Drivers of buyer power in the pharmaceuticals market in Belgium, 2013
Figure 7: Drivers of supplier power in the pharmaceuticals market in Belgium, 2013
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Belgium, 2013
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Belgium, 2013
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Belgium, 2013
Figure 11: AstraZeneca PLC: revenues & profitability
Figure 12: AstraZeneca PLC: assets & liabilities
Figure 13: GlaxoSmithKline Plc: revenues & profitability
Figure 14: GlaxoSmithKline Plc: assets & liabilities
Figure 15: Pfizer Inc.: revenues & profitability
Figure 16: Pfizer Inc.: assets & liabilities

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos